Although both are characterized by the anomalous accumulation of tau aggregates in specific brain regions, we should be aware that FTD and AD are two distinct neurodegenerative diseases, with different genetic profiles, molecular drivers, and clinical signs. The gene discussed is MAPT; the disease is frontotemporal dementia.